4//SEC Filing
Roth David 4
Accession 0000950170-24-042289
CIK 0001556263other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:30 PM ET
Size
4.7 KB
Accession
0000950170-24-042289
Insider Transaction Report
Form 4
Roth David
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-04-03$4.95/sh−10,451$51,732→ 0 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a trading plan adopted on March 27, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001599014
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:30 PM ET
- Size
- 4.7 KB